Lisenn Lalier

1.7k total citations
20 papers, 1.3k citations indexed

About

Lisenn Lalier is a scholar working on Molecular Biology, Cancer Research and Pharmacology. According to data from OpenAlex, Lisenn Lalier has authored 20 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 6 papers in Cancer Research and 3 papers in Pharmacology. Recurrent topics in Lisenn Lalier's work include Cell death mechanisms and regulation (6 papers), Epigenetics and DNA Methylation (6 papers) and Mitochondrial Function and Pathology (5 papers). Lisenn Lalier is often cited by papers focused on Cell death mechanisms and regulation (6 papers), Epigenetics and DNA Methylation (6 papers) and Mitochondrial Function and Pathology (5 papers). Lisenn Lalier collaborates with scholars based in France and United Kingdom. Lisenn Lalier's co-authors include François M. Vallette, Pierre‐François Cartron, Lisa Oliver, Olivier D. Christophe, Stéphen Manon, Svetlana Nedelkina, Philippe Juin, Claire Pecqueur, Dominique Heymann and Mathilde Cheray and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Oncogene.

In The Last Decade

Lisenn Lalier

20 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lisenn Lalier France 19 903 352 234 135 110 20 1.3k
Laura Braccini Italy 8 880 1.0× 273 0.8× 239 1.0× 86 0.6× 160 1.5× 12 1.3k
Maria Chiara De Santis Italy 14 1.0k 1.2× 333 0.9× 287 1.2× 107 0.8× 124 1.1× 18 1.6k
Yong Jae Shin South Korea 19 598 0.7× 202 0.6× 218 0.9× 119 0.9× 171 1.6× 31 1.1k
Helena L. Borges Brazil 20 771 0.9× 176 0.5× 333 1.4× 144 1.1× 109 1.0× 40 1.2k
Olaf Merkel Austria 21 921 1.0× 452 1.3× 300 1.3× 129 1.0× 235 2.1× 40 1.5k
Wei Han China 24 928 1.0× 504 1.4× 208 0.9× 117 0.9× 143 1.3× 80 1.5k
Wenan Qiang United States 30 860 1.0× 343 1.0× 325 1.4× 56 0.4× 167 1.5× 67 1.9k
Caiping Chen China 21 782 0.9× 215 0.6× 214 0.9× 100 0.7× 161 1.5× 68 1.5k
Vidya Gopalakrishnan United States 27 1.4k 1.6× 245 0.7× 319 1.4× 249 1.8× 115 1.0× 81 1.9k
A. Pieter J. van den Heuvel United States 13 967 1.1× 335 1.0× 363 1.6× 57 0.4× 132 1.2× 14 1.4k

Countries citing papers authored by Lisenn Lalier

Since Specialization
Citations

This map shows the geographic impact of Lisenn Lalier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisenn Lalier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisenn Lalier more than expected).

Fields of papers citing papers by Lisenn Lalier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisenn Lalier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisenn Lalier. The network helps show where Lisenn Lalier may publish in the future.

Co-authorship network of co-authors of Lisenn Lalier

This figure shows the co-authorship network connecting the top 25 collaborators of Lisenn Lalier. A scholar is included among the top collaborators of Lisenn Lalier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisenn Lalier. Lisenn Lalier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lalier, Lisenn, François M. Vallette, & Stéphen Manon. (2022). Bcl-2 Family Members and the Mitochondrial Import Machineries: The Roads to Death. Biomolecules. 12(2). 162–162. 43 indexed citations
2.
Christophe, Olivier D., Lisa Oliver, Lisenn Lalier, & François M. Vallette. (2021). Drug Resistance in Glioblastoma: The Two Faces of Oxidative Stress. Frontiers in Molecular Biosciences. 7. 620677–620677. 130 indexed citations
3.
Lalier, Lisenn, et al.. (2021). TOM20-mediated transfer of Bcl2 from ER to MAM and mitochondria upon induction of apoptosis. Cell Death and Disease. 12(2). 182–182. 44 indexed citations
4.
Joalland, Marie‐Pierre, Lisa Oliver, Claire Pecqueur, et al.. (2020). Sphingolipid distribution at mitochondria-associated membranes (MAMs) upon induction of apoptosis. Journal of Lipid Research. 61(7). 1025–1037. 40 indexed citations
5.
Oliver, Lisa, et al.. (2020). Drug resistance in glioblastoma: are persisters the key to therapy?. Cancer Drug Resistance. 3(3). 287–301. 52 indexed citations
6.
Vallette, François M., Olivier D. Christophe, Frédéric Lézot, et al.. (2018). Dormant, quiescent, tolerant and persister cells: Four synonyms for the same target in cancer. Biochemical Pharmacology. 162. 169–176. 123 indexed citations
7.
Raimbourg, Judith, Marie‐Pierre Joalland, Mathilde Cabart, et al.. (2017). Sensitization of EGFR Wild-Type Non–Small Cell Lung Cancer Cells to EGFR-Tyrosine Kinase Inhibitor Erlotinib. Molecular Cancer Therapeutics. 16(8). 1634–1644. 17 indexed citations
8.
Oizel, Kristell, Lisenn Lalier, Claire Pecqueur, et al.. (2015). Radiation-induced PGE2sustains human glioma cell growth and survival through EGF signaling. Oncotarget. 6(9). 6840–6849. 37 indexed citations
9.
Lalier, Lisenn, et al.. (2014). The DNMT1/PCNA/UHRF1 disruption induces tumorigenesis characterized by similar genetic and epigenetic signatures. Scientific Reports. 4(1). 4230–4230. 41 indexed citations
10.
Morfouace, Marie, Lisenn Lalier, Lisa Oliver, et al.. (2014). Control of glioma cell death and differentiation by PKM2–Oct4 interaction. Cell Death and Disease. 5(1). e1036–e1036. 72 indexed citations
11.
Lalier, Lisenn, et al.. (2014). Bioactive lipids and the control of Bax pro-apoptotic activity. Cell Death and Disease. 5(5). e1266–e1266. 42 indexed citations
12.
Cartron, Pierre‐François, et al.. (2013). Identification of TET1 Partners That Control Its DNA-Demethylating Function. Genes & Cancer. 4(5-6). 235–241. 58 indexed citations
13.
Pecqueur, Claire, Lisa Oliver, Kristell Oizel, Lisenn Lalier, & François M. Vallette. (2013). Targeting Metabolism to Induce Cell Death in Cancer Cells and Cancer Stem Cells. International Journal of Cell Biology. 2013. 1–13. 62 indexed citations
14.
Morfouace, Marie, Lisenn Lalier, Muriel Bahut, et al.. (2012). Comparison of Spheroids Formed by Rat Glioma Stem Cells and Neural Stem Cells Reveals Differences in Glucose Metabolism and Promising Therapeutic Applications. Journal of Biological Chemistry. 287(40). 33664–33674. 55 indexed citations
15.
Lalier, Lisenn, et al.. (2011). Increase in intracellular PGE2 induces apoptosis in Bax-expressing colon cancer cell. BMC Cancer. 11(1). 153–153. 29 indexed citations
16.
Lalier, Lisenn, Pierre‐François Cartron, Olivier D. Christophe, et al.. (2010). Prostaglandins antagonistically control Bax activation during apoptosis. Cell Death and Differentiation. 18(3). 528–537. 40 indexed citations
17.
Hervouet, Éric, Lisenn Lalier, Emilie Debien, et al.. (2010). Disruption of Dnmt1/PCNA/UHRF1 Interactions Promotes Tumorigenesis from Human and Mice Glial Cells. PLoS ONE. 5(6). e11333–e11333. 113 indexed citations
18.
Lalier, Lisenn, Pierre‐François Cartron, Olivier D. Christophe, et al.. (2007). Increase in PGE2 biosynthesis induces a Bax dependent apoptosis correlated to patients’ survival in glioblastoma multiforme. Oncogene. 26(34). 4999–5009. 54 indexed citations
19.
Lalier, Lisenn, et al.. (2007). Control of Bax Homodimerization by Its Carboxyl Terminus. Journal of Biological Chemistry. 282(34). 24938–24947. 19 indexed citations
20.
Lalier, Lisenn, Pierre‐François Cartron, Philippe Juin, et al.. (2007). Bax activation and mitochondrial insertion during apoptosis. APOPTOSIS. 12(5). 887–896. 278 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026